Characterization of the novel KIR3DL2 allele, KIR3DL2*113.
KIR3DL2
novel allele
polymerase chain reaction sequence-based typing
Journal
HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
19
01
2020
revised:
27
01
2020
accepted:
01
02
2020
pubmed:
7
2
2020
medline:
22
6
2021
entrez:
7
2
2020
Statut:
ppublish
Résumé
The new allele KIR3DL2*113 showed one nucleotide difference with KIR3DL2*0020101 at codon 345.
Substances chimiques
KIR3DL2 protein, human
0
Receptors, KIR3DL2
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
594-596Informations de copyright
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Gwozdowicz S, Nestorowicz K, Graczyk-Pol E, et al. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules. Int J Immunogenet. 2019;46(4):217-231.
Weisdorf D, Cooley S, Wang T, et al. KIR donor selection: feasibility in identifying better donors. Biol Blood Marrow Transplant. 2019;25(1):e28-e32.
Torío A, Pascual MJ, Vidales I, Ortiz M, Caballero A, Heiniger AI. Donor selection based on killer cell immunoglobulin-like receptor (KIR) genotype may improve outcome after T-cell-replete Haploidentical transplantation. Transplant Proc. 2018;50(2):679-682.
Augusto DG, Petzl-Erler ML. KIR and HLA under pressure: evidences of coevolution across worldwide populations. Hum Genet. 2015;134(9):929-940.
Marsh SGE, Parham P, Dupont B, et al. Killer-cell immunoglobulin-like receptor (KIR) Nomenclature Report, 2002. Tissue Antigens. 2003;62(1):79-86.